Interestingly, when evaluating the amplification of c-Myc and HSF1 genes in the same human HCC subset, we found that 8 of 64 (12.5%) and 24 of 64 (37.5%) HCC exhibited c-Myc and HSF1 amplification, respectively (Figure 7). This evidence concerns the gene MYC and hepatocellular carcinoma.